# Ana Farinha

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/ana-farinha/

## Facts

| Field | Value |
| --- | --- |
| Citations | 746 |
| Field | Dialysis and Renal Disease Management |
| h-index | 9 |
| i10-index | 9 |
| Last Known Institution | Administração Regional de Saúde de Lisboa e Vale do Tejo |
| OpenAlex ID | https://openalex.org/A5022285414 |
| ORCID iD | 0000-0002-5402-7626 |
| Works | 63 |

## Researcher papers

- [Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial](https://scholariq.org/papers/efficacy-and-safety-of-sparsentan-versus-irbesartan-in-patients-with-iga/)
- [Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial](https://scholariq.org/papers/sparsentan-in-patients-with-iga-nephropathy-a-prespecified-interim-analysis-from/)
- [Cognitive disorders in patients with chronic kidney disease: Approaches to prevention and treatment](https://scholariq.org/papers/cognitive-disorders-in-patients-with-chronic-kidney-disease-approaches-to/)
- [Cognitive impairment in CKD patients: a guidance document by the CONNECT network](https://scholariq.org/papers/cognitive-impairment-in-ckd-patients-a-guidance-document-by-the-connect-network/)
- [Drugs with a negative impact on cognitive function (Part 1): chronic kidney disease as a risk factor](https://scholariq.org/papers/drugs-with-a-negative-impact-on-cognitive-function-part-1-chronic-kidney-disease/)
- [The role of the intestinal microbiome in cognitive decline in patients with kidney disease](https://scholariq.org/papers/the-role-of-the-intestinal-microbiome-in-cognitive-decline-in-patients-with/)
- [Methodological challenges and biases in the field of cognitive function among patients with chronic kidney disease](https://scholariq.org/papers/methodological-challenges-and-biases-in-the-field-of-cognitive-function-among/)
- [Cognitive impairment in kidney transplanted patients](https://scholariq.org/papers/cognitive-impairment-in-kidney-transplanted-patients/)
- [Genetic and circulating biomarkers of cognitive dysfunction and dementia in CKD](https://scholariq.org/papers/genetic-and-circulating-biomarkers-of-cognitive-dysfunction-and-dementia-in-ckd/)
- [Anemia da Doença Renal Crónica: O Estado da Arte](https://scholariq.org/papers/anemia-da-doenca-renal-cronica-o-estado-da-arte/)
- [Emerging perspectives in the management of IgA nephropathy: a comprehensive review](https://scholariq.org/papers/emerging-perspectives-in-the-management-of-iga-nephropathy-a-comprehensive/)

## Researcher topics

- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Palliative Care and End-of-Life Issues](https://scholariq.org/topics/palliative-care-and-end-of-life-issues/)
- [Frailty in Older Adults](https://scholariq.org/topics/frailty-in-older-adults/)
- [Dementia and Cognitive Impairment Research](https://scholariq.org/topics/dementia-and-cognitive-impairment-research/)

## Researcher university

- [Administração Regional de Saúde de Lisboa e Vale do Tejo](https://scholariq.org/institutions/administracao-regional-de-saude-de-lisboa-e-vale-do-tejo/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.